Loading: 100%
RESMED INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 6,080 (as per Q3 2017)no data available
Sector Medical Instruments & Equipmen, HealthcareMedical Instruments & Equipmen, Healthcareno data available
Ticker RMDno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 175058667482
datesClosing price (adj.)
13.10.201777.63
11.10.201776.55
04.10.201777.27
27.09.201776.16
20.09.201779.60
13.09.201779.61
06.09.201777.66
30.08.201775.58
23.08.201773.91
16.08.201772.70
09.08.201773.76
02.08.201772.16
26.07.201777.29
19.07.201777.68
12.07.201776.73
05.07.201776.71
27.06.201776.65
20.06.201778.09
13.06.201774.80
06.06.201772.20
30.05.201769.66
23.05.201769.27
16.05.201768.15
09.05.201767.14
02.05.201769.12
25.04.201770.26
18.04.201767.99
11.04.201768.76
04.04.201769.87
28.03.201771.27
21.03.201770.04
14.03.201770.31
07.03.201770.83
28.02.201771.33
21.02.201771.51
14.02.201770.38
07.02.201768.26
31.01.201766.57
24.01.201768.72
17.01.201763.26
10.01.201763.33
03.01.201761.06
27.12.201660.97
19.12.201661.40
12.12.201661.87
05.12.201659.07
28.11.201659.74
21.11.201657.68
14.11.201657.72
07.11.201656.80
31.10.201658.58
24.10.201662.49
17.10.201662.90
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
77.63n/a
Market Capitalisation
in million USD
11,009n/a
Enterprise Value
in million USD
11,453n/a
Common Shares Outstanding
as per Apr 20, 2017
141,819,243n/a
Preferred Shares Outstanding
as per Apr 20, 2017
n/a
Average Basic Shares Outstanding
TTM
141,086,000n/a
Average Diluted Shares Outstanding
TTM
142,407,750n/a
Index Membership
n/a
Business Summary
ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 731n/a
Receivables 382n/a
Total Current Assets 1,420n/a
PP&E 384n/a
Total Assets 3,259n/a
Accounts Payable 93n/a
Current Debt 300n/a
Total Current Liabilities 639n/a
Long-Term Debt 875n/a
Total Liabilities 1,564n/a
Total Equity 1,695n/a
Cash Flow
Depreciation & Amortisation 87n/a
Change in Working Capital 62n/a
Operating Cash Flow 548n/a
Net Change in PP&E and Intangibles -68n/a
Investing Cash Flow -1,126n/a
Dividends Paid -168n/a
Financing Cash Flow 613n/a
Total Change in Cash 14n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.15n/a
Other Ratios
Current Ratio 222.3%n/a
Liabilities to Equity Ratio 92.3%n/a
Debt to Assets Ratio 36.1%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
921
1,092
1,243
1,369
1,514
1,555
1,679
1,839
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-367
-437
-502
-548
-574
-565
-668
-772
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
554
655
741
821
941
990
1,011
1,066
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-360
-412
-474
-526
-586
-578
-602
-631
Selling, General & Administrative
-290
-329
-372
-403
-431
-450
-479
-488
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-63
-75
-92
-110
-120
-118
-115
-119
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
-7
-8
-10
-14
-35
-10
-9
-24
Operating Income (Loss)
194
243
267
294
355
411
409
436
Non-Operating Income (Loss)
-9
-13
-19
-30
-47
-36
-26
-23
Interest Expense, net
-10
-19
-30
-39
-45
-37
-32
-28
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
1
6
11
8
-2
1
6
5
Pretax Income (Loss), Adjusted
185
230
248
264
307
375
384
413
Abnormal Gains (Losses)
-4
-3
0
0
0
-6
0
-7
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
181
227
248
264
307
369
384
406
Income Tax (Expense) Benefit, net
-55
-71
-77
-77
-78
-86
-83
-87
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
126
157
171
187
229
283
300
319
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
126
157
171
187
229
283
300
319
Minority Interest
0
0
0
0
0
0
0
0
Net Income
126
157
171
187
229
283
300
319
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
126
157
171
187
229
283
300
319
Remarks
restated on Aug 17, 2011 n/a
calculated values,
restated on Aug 14, 2012 n/a
calculated values,
restated on Aug 13, 2013 n/a
calculated values,
restated on Aug 8, 2014 n/a
calculated values,
restated on Aug 7, 2015 n/a
calculated values,
restated on Aug 5, 2016 n/a
calculated values,
restated on Aug 5, 2016 n/a
calculated values,
restated on Aug 5, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
489
735
810
876
906
717
731
Cash & Cash Equivalents
n/a
489
735
810
876
906
717
731
Short Term Investments
n/a
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
227
274
283
318
360
363
382
Accounts Receivable, Net
n/a
227
274
283
318
360
363
382
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
186
201
174
146
165
247
224
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
84
82
94
109
125
81
82
Prepaid Expenses
n/a
65
59
72
61
94
81
82
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
14
14
20
39
32
0
0
Income Taxes Receivable
n/a
5
9
2
9
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
985
1,292
1,361
1,449
1,556
1,408
1,420
Property, Plant & Equipment, Net
n/a
387
462
434
411
434
388
384
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
254
314
342
350
370
386
1,455
Intangible Assets
n/a
0
0
0
0
0
0
0
Goodwill
n/a
199
0
0
0
0
264
1,059
Other Intangible Assets
n/a
31
283
311
324
335
47
300
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
19
19
24
20
19
46
55
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
5
12
8
6
17
28
40
Total Noncurrent Assets
n/a
641
776
777
762
805
774
1,839
Total Assets
n/a
1,626
2,069
2,138
2,211
2,361
2,182
3,259
Liabilities and owners' equity
Payables & Accruals
n/a
161 161074000
163 162912000
210 210164000
228 228452000
226 226453000
230 230366000
289 288542000
Accounts Payable
n/a
58 57535000
55 55194000
55 55006000
61 60688000
85 85405000
81 81112000
93 92571000
Accrued Taxes
n/a
23 22656000
4 3931000
28 27777000
30 30090000
10 10392000
16 16278000
39 39166000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
81 80883000
104 103787000
127 127381000
138 137674000
131 130656000
133 132976000
157 156805000
Short Term Debt
n/a
122 121689000
0 163000
0 52000
300 300017000
0 18000
0 0
300 300000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
30 29909000
46 45765000
43 42636000
46 45580000
43 43087000
36 36097000
50 50009000
Deferred Revenue
n/a
30 29507000
45 45125000
42 41563000
45 44953000
42 42370000
36 36097000
50 50009000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 402000
1 640000
1 1073000
1 627000
1 717000
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
n/a
313 312672000
209 208840000
253 252852000
574 574049000
270 269558000
266 266463000
639 638551000
Long Term Debt
n/a
0 0
100 100000000
251 250783000
1 769000
301 300770000
301 300594000
875 875000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
26 26189000
29 29345000
27 26607000
25 25387000
32 32386000
27 27410000
51 50553000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
13 12755000
17 17237000
14 14384000
12 11928000
16 16352000
19 19284000
40 40281000
Deferred Tax Liabilities
n/a
11 10793000
8 8051000
9 8843000
10 9895000
11 10716000
6 6372000
9 9061000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
3 2641000
4 4057000
3 3380000
4 3564000
5 5318000
2 1754000
1 1211000
Total Noncurrent Liabilities
n/a
26 26189000
129 129345000
277 277390000
26 26156000
333 333156000
328 328004000
926 925553000
Total Liabilities
n/a
339 338861000
338 338185000
530 530242000
600 600205000
603 602714000
594 594467000
1,564 1564104000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
661 660790000
799 799068000
900 900285000
1,026 1025632000
1,118 1118205000
1,229 1229357000
1,304 1303801000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-345 -344505000
-505 -504625000
-896 -895826000
-1,084 -1083845000
-1,292 -1291910000
-1,445 -1444554000
-1,547 -1546611000
Retained Earnings
n/a
885 884876000
1,112 1111862000
1,367 1366712000
1,577 1576641000
1,780 1780396000
1,976 1976020000
2,160 2160299000
Other Equity
n/a
86 86375000
324 324432000
236 236456000
92 92088000
152 151557000
-174 -173516000
-223 -222658000
Equity Before Minority Interest
n/a
1,288 1287536000
1,731 1730737000
1,608 1607627000
1,611 1610516000
1,758 1758248000
1,587 1587307000
1,695 1694831000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
1,288 1287536000
1,731 1730737000
1,608 1607627000
1,611 1610516000
1,758 1758248000
1,587 1587307000
1,695 1694831000
Total Liabilities & Equity
n/a
1,626 1626397000
2,069 2068922000
2,138 2137869000
2,211 2210721000
2,361 2360962000
2,182 2181774000
3,259 3258935000
Remarks restated on n/a restated on Aug 17, 2011 n/a restated on Aug 14, 2012 n/a restated on Aug 13, 2013 n/a restated on Aug 8, 2014 n/a restated on Aug 7, 2015 n/a restated on Aug 5, 2016 n/a restated on Apr 28, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
146
190
227
255
307
345
353
352
Net Income
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Depreciation & Amortization
54
62
71
86
78
73
73
87
Non-Cash Items
15
16
1
9
18
21
22
47
Stock-Based Compensation
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
Change in Working Capital
23
-79
-16
34
-1
-48
-65
62
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
Cash from Operating Activities
239
188
283
383
403
391
383
548
Change in Fixed Assets & Intangibles
-109
-61
-73
-61
-72
-81
-72
-68
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
-2
1
2
-5
-2
-11
-11
-9
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-2
-11
-22
-53
-5
-4
-29
-1,042
Net Cash from Divestitures
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
Other Investing Activities
5
12
17
18
1
1
-31
-7
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
Cash from Investing Activities
-109
-58
-77
-102
-78
-95
-143
-1,126
Dividends Paid
0
0
0
0
-97
-142
-157
-168
Cash From (Repayment of) Debt
42
-38
-25
144
50
-2
-2
856
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-44
-36
-69
-330
-117
-169
-121
-74
Increase in Capital Stock
25
95
95
62
69
33
39
28
Decrease in Capital Stock
-69
-131
-163
-393
-186
-202
-160
-102
Other Financing Activities
4
13
15
9
11
15
25
-1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
Cash from Financing Activities
2
-61
-79
-177
-154
-297
-256
613
Net Cash Before Disc. Operations and FX
131
69
127
104
171
-1
-16
35
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
Net Cash Before FX
131
69
127
104
171
-1
-16
35
Effect of Foreign Exchange Rates
-37
4
119
-30
-104
31
-173
-21
Net Changes in Cash
95
73
246
74
67
30
-188
14
Remarks
restated on Aug 17, 2011 n/a
calculated values,
restated on Aug 14, 2012 n/a
calculated values,
restated on Aug 13, 2013 n/a
calculated values,
restated on Aug 8, 2014 n/a
calculated values,
restated on Aug 7, 2015 n/a
calculated values,
restated on Aug 5, 2016 n/a
calculated values,
restated on Aug 5, 2016 n/a
calculated values,
restated on Aug 5, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo